DESI-MS Solvent Composition for Tissue-Safe Lipid Imaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current mass spectral analysis techniques, such as DESI-MS, often destroy native tissue morphology, making it difficult to perform subsequent histochemical analyses on the same tissue section, which is essential for accurate histopathological evaluation and cancer diagnosis.

Innovation Solution

The use of non-destructive solvent systems like DMF:EtOH and DMF:H2O allows for DESI-MS imaging without damaging the tissue morphology, enabling subsequent H&E staining and immunohistochemistry, thereby preserving the tissue integrity for comprehensive analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional DESI-MS solvent systems (methanol/water or acetonitrile/water) are used, then mass spectral analysis can be performed, but native tissue morphology is destroyed

Engineering Contradiction:
Improvemass spectral analysis capabilityVSAvoidtissue morphology
Core Design Contradiction:
Measurement precisionVSShape

Solution Approach 1:

The patent changes the chemical composition parameters of the DESI solvent system by replacing conventional methanol/water or acetonitrile/water mixtures with morphologically friendly solvent systems containing dimethylformamide (DMF) combined with ethanol or water. This parameter change in solvent chemistry enables mass spectral analysis while preserving tissue morphology, as DMF-based systems do not extract cellular components that maintain tissue structure.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If the same tissue section is used for both MS imaging and histochemical staining, then workflow efficiency is improved, but tissue morphology must be preserved through non-destructive analysis

Engineering Contradiction:
Improveworkflow efficiencyVSAvoidtissue morphology
Core Design Contradiction:
ProductivityVSShape

Solution Approach 1:

The patent makes the tissue section universally suitable for multiple analytical functions by using DMF-based DESI solvent systems that preserve morphology. The same tissue section can subsequently undergo H&E staining, immunohistochemistry, or other histochemical procedures, enabling multi-functional use of a single section and improving workflow efficiency without sacrificing morphological integrity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Shape

If morphologically friendly solvent systems (DMF:EtOH or DMF:H2O) are used, then tissue morphology is preserved, but conventional DESI-MS protocols must be modified

Engineering Contradiction:
Improvetissue morphologyVSAvoidprotocol complexity
Core Design Contradiction:
ShapeVSDevice complexity

Solution Approach 1:

The patent modifies the chemical parameters of the DESI solvent system by incorporating DMF as the primary solvent component combined with ethanol or water. This parameter change in solvent composition enables morphology preservation while maintaining compatibility with standard DESI-MS instrumentation, requiring only solvent system modification rather than fundamental protocol redesign.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables high-quality 2D DESI-MS ion images to be directly compared with H&E stained tissue sections, improving the correlation between lipid species distribution and tissue substructures, and allows for accurate cancer diagnosis without causing morphological damage to the tissue.

Implementation Method 1

desorption electrospray ionization mass spectrometry (DESI-MS)

Methodology Applied
Scientific EffectDesorption electrospray ionization:

Data Source

PatentUS11860172B2Mass spectral tissue analysis
Publication Date: 2024.01.02 PURDUE RES FOUND
  • US11860172B2 patent drawing
  • US11860172B2 patent drawing
  • US11860172B2 patent drawing

AI summary

The invention generally relates to mass spectral analysis. In certain embodiments, methods of the invention involve analyzing a lipid containing sample using a mass spectrometry technique, in which the technique utilizes a liquid phase that does not destroy native tissue morphology during analysis. Due to the use of a liquid phase that does not destroy native tissue morphology during analysis, a subsequent staining technique can be performed on the tissue sample and an overlaid image can be produced of a mass spectral image and a staining image.